- Home
- /
- The HAE journey in...
Chair: Prof. Dr Petra Staubach
A discussion-based webinar, led by HAE experts, on the management and treatment of HAE around pregnancy. Considerations during preconception and family-planning stages, pregnancy and postpartum will be discussed with complementary patient cases.
Webinar agenda
A holistic approach to managing female patients with HAE who wish to become pregnant, Dr. Krasimira Baynova, Spain
The use of subcutaneous plasma-derived C1 inhibitor in prophylaxis of acute attacks of HAE in pregnant patients, Prof. Dr. Miloš Jeseňák, Slovakia
From birth to breastfeeding and beyond with plasma-derived C1 inhibitor treatment, Dr. Thomas Buttgereit, Germany
View individual presentations
Duration: 16:14
A holistic approach to managing female patients with HAE who wish to become pregnant
Dr Krasimira Baynova, Spain
Dr Krasimira Baynova presents a clinical case involving a holistic HAE management plan during the preconception period, where long-term prophylaxis HAE treatment was adapted and psychological support provided.
Duration: 18:02
The use of subcutaneous plasma-derived C1 inhibitor in prophylaxis of acute attacks of HAE in pregnant patients
Prof. Dr Miloš Jeseňák, Slovakia
Prof. Dr Miloš Jeseňák presents patient cases and identifies key considerations for managing acute attacks during pregnancy. He highlights that HAE during pregnancy should be treated as a special situation that requires a highly individualised treatment approach.
Duration: 22:09
From birth to breastfeeding and beyond with plasma-derived C1 inhibitor treatment
Dr Thomas Buttgereit, Germany
Dr Thomas Buttgereit discusses the special considerations and treatment recommendations for patients with HAE who are preparing for labour and who will be breastfeeding. He presents a clinical case highlighting the need for individualised treatment plans.
